Skip to content

A Randomized, Double-Blind, Sham-Controlled Trial of Transcutaneous Auricular Vagus Nerve Stimulation as an Adjunct to General Anesthesia

A Randomized, Double-Blind, Sham-Controlled Trial of Transcutaneous Auricular Vagus Nerve Stimulation as an Adjunct to General Anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124716
Enrollment
Unknown
Registered
2026-05-15
Start date
2026-05-18
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic surgery

Interventions

Control group:Transcutaneous vagus nerve pseudo stimulation

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Elective abdominal surgery under general anesthesia (including laparoscopic cholecystectomy, appendectomy, hernia surgery, etc.), with an estimated operation duration of 1 to 3 hours; 2.Age: 18 to 65 years old; 3.ASA physical status: Class ? to ?; 4.BMI: 18.5 to 28 kg/m^2; 5.Clear consciousness and normal communication capability; 6.Voluntary participation in this study with signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with damaged, infected or deformed ear skin, unable to place electrodes; 2. Patients with known vagus nerve dysfunction or a history of neck surgery; 3. Patients with severe cardiovascular diseases (NYHA grades ?-?, severe arrhythmia, implanted pacemaker/ICD); 4. Patients with neurological diseases (epilepsy, Parkinson's disease, history of stroke); 5. Patients who have been using analgesics, sedatives or antidepressants for a long time; 6. Patients with hearing impairment or those who cannot understand the research process; 7. Pregnant or lactating women; 8. Patients participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
The dosage of propofol during the induction period of anesthesia;

Secondary

MeasureTime frame
The cumulative dosage of analgesic drugs within 24 hours after the operation;The dosage of propofol and remifentanil during the maintenance period of anesthesia;Anesthesia depth monitoring indicators;Hemodynamic indicators;Quality indicators of awakening;NRS scores at each postoperative time point;Postoperative adverse events;

Countries

China

Contacts

Public ContactLi Xianglong

Guangdong Provincial Hospital of Traditional Chinese Medicine

19202044926@163.com+86 192 0204 4926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 22, 2026